ANTI-DIABETES DRUG METFORMIN RECALLED OVER DOUBTS OF CONTAINING CANCER-CAUSING COMPOUND

Highlights

• The USFDA has previously released an alert in the month of May, where it had stated agency laboratory testing of several lots of extended-release (ER) metformin revealed levels of N-Nitrosodimethylamine (NDMA) above prescribed limit

• Metformin, a drug used to treat type 2 diabetes is sold under brand names Fortamet, Glucophage, Glucophage XR, Glumetza and Riomet

• As per the FDA, consu....